To explore the in vivo role of FGF19 in cholesterol homeostasis in the context of diabetes, a global health concern that is frequently associated with dyslipidemia, we introduced and expressed FGF19 transgenes in diabetic db/db mice by intravenous AAV delivery methods (Fig. 1A). The gene discussed is FGF19; the disease is diabetes mellitus.